Ken Fisher’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $440K | Sell |
1,648
-106
| -6% | -$28.7K | ﹤0.01% | 815 |
|
|
2025
Q4 | $440K | Buy |
1,754
+24
| +1% | +$6.37K | ﹤0.01% | 798 |
|
|
2025
Q3 | $497K | Buy |
1,730
+70
| +4% | +$18.8K | ﹤0.01% | 780 |
|
|
2025
Q2 | $436K | Sell |
1,660
-168
| -9% | -$40.9K | ﹤0.01% | 809 |
|
|
2025
Q1 | $426K | Sell |
1,828
-205
| -10% | -$49.7K | ﹤0.01% | 821 |
|
|
2024
Q4 | $466K | Buy |
2,033
+784
| +63% | +$180K | ﹤0.01% | 786 |
|
|
2024
Q3 | $279K | Buy |
1,249
+2
| +0.2% | +$440 | ﹤0.01% | 845 |
|
|
2024
Q2 | $254K | Buy |
1,247
+128
| +11% | +$26K | ﹤0.01% | 907 |
|
|
2024
Q1 | $244K | Sell |
1,119
-346
| -24% | -$76.2K | ﹤0.01% | 902 |
|
|
2023
Q4 | $333K | Buy |
1,465
+248
| +20% | +$52.1K | ﹤0.01% | 847 |
|
|
2023
Q3 | $245K | Sell |
1,217
-202
| -14% | -$42.6K | ﹤0.01% | 980 |
|
|
2023
Q2 | $294K | Hold |
1,419
| – | – | ﹤0.01% | 957 |
|
|
2023
Q1 | $280K | Sell |
1,419
-147
| -9% | -$30.2K | ﹤0.01% | 928 |
|
|
2022
Q4 | $317K | Sell |
1,566
-220
| -12% | -$43K | ﹤0.01% | 908 |
|
|
2022
Q3 | $314K | Sell |
1,786
-1,293
| -42% | -$265K | ﹤0.01% | 818 |
|
|
2022
Q2 | $620K | Sell |
3,079
-70
| -2% | -$14.9K | ﹤0.01% | 686 |
|
|
2022
Q1 | $713K | Sell |
3,149
-180
| -5% | -$42.3K | ﹤0.01% | 666 |
|
|
2021
Q4 | $899K | Sell |
3,329
-1,381
| -29% | -$342K | ﹤0.01% | 662 |
|
|
2021
Q3 | $1.14M | Buy |
4,710
+62
| +1% | +$15.6K | ﹤0.01% | 599 |
|
|
2021
Q2 | $1.1M | Sell |
4,648
-197
| -4% | -$44.9K | ﹤0.01% | 592 |
|
|
2021
Q1 | $1.06M | Sell |
4,845
-125
| -3% | -$25.1K | ﹤0.01% | 603 |
|
|
2020
Q4 | $869K | Buy |
4,970
+167
| +3% | +$28.8K | ﹤0.01% | 615 |
|
|
2020
Q3 | $777K | Sell |
4,803
-2,531
| -35% | -$401K | ﹤0.01% | 592 |
|
|
2020
Q2 | $1.05M | Buy |
7,334
+221
| +3% | +$30.6K | ﹤0.01% | 560 |
|
|
2020
Q1 | $772K | Sell |
7,113
-509
| -7% | -$73.3K | ﹤0.01% | 567 |
|
|
2019
Q4 | $1.11M | Sell |
7,622
-54,221
| -88% | -$7.83M | ﹤0.01% | 573 |
|
|
2019
Q3 | $8.93M | Sell |
61,843
-5
| -0% | -$730 | 0.01% | 376 |
|
|
2019
Q2 | $9.19M | Sell |
61,848
-582
| -0.9% | -$81.2K | 0.01% | 369 |
|
|
2019
Q1 | $8.21M | Sell |
62,430
-3,761
| -6% | -$463K | 0.01% | 374 |
|
|
2018
Q4 | $7.18M | Buy |
66,191
+3,748
| +6% | +$502K | 0.01% | 374 |
|
|
2018
Q3 | $9.32M | Sell |
62,443
-6,127
| -9% | -$932K | 0.01% | 358 |
|
|
2018
Q2 | $10.6M | Sell |
68,570
-1,986
| -3% | -$300K | 0.01% | 341 |
|
|
2018
Q1 | $9.8M | Sell |
70,556
-908
| -1% | -$133K | 0.01% | 345 |
|
|
2017
Q4 | $9.79M | Sell |
71,464
-4,775
| -6% | -$631K | 0.01% | 342 |
|
|
2017
Q3 | $9.89M | Buy |
+76,239
| New | +$10.2M | 0.01% | 327 |
|
Other funds holding LH
VCM
VPM
Ken Fisher's LH Position: Q1 2026 in Review
Ken Fisher reduced its Labcorp (LH) stake by 6% in Q1 2026, selling an estimated $28.7K and leaving 1,648 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #815.
Ken Fisher first reported a position in LH in Q3 2017 and has held it in 35 quarters since. The position peaked at $10.6M in Q2 2018. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Ken Fisher held 1,648 shares of Labcorp worth $440K as of Q1 2026.
- Ken Fisher sold 106 Labcorp shares in Q1 2026, an estimated $28.7K.
- Labcorp made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #815 holding.
- Ken Fisher first reported a position in Labcorp in Q3 2017 and has held it in 35 quarters since.
- Ken Fisher's Labcorp position peaked at $10.6M in Q2 2018.
- 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.